Groovy.Bio SComm
0.2 FTEGroovy.Bio reported total assets of 744,069 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026), with 0.2 full-time equivalent.
The score of Groovy.Bio shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +509 % Total assets +700 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Groovy.Bio's annual accounts
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Net result | −297,520 € | |||
| Equity | 544,484 € | |||
| Cash | 694,335 € | |||
| EBITDA | −29,778 € | |||
| Total assets | 744,069 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 11 Apr 2025
- Year ended 31 Dec 2023filed on 03 Apr 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
Groovy.Bio's financial analysis
- Solvency73.2%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Groovy.Bio
Groovy.Bio's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0776.937.633
- VAT number
- BE0776937633
- Peppol
- Registered · 0208:0776937633 · as of 10 Nov 2026
- Legal form
- SComm
- Incorporated
- 08 Nov 2021
- Registered office
- 9940 Evergem
- Size
- Micro · 0.2 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Groovy.Bio (SComm) has been based in Evergem since 2021, active in: manufacture of medicaments. For 2025, it reports a net loss of 297,520 € and equity of 544,484 €; its revenue is not published. With 0.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 73.2%, above the median of its sector (47.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Groovy.Bio
Companies in the same business, of comparable size and area, outside its group.
- ExoXpert Manufacture of pharmaceutical preparations Liège · balance sheet €2.05m
- Alnylam Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet €1.20m
- FLGM Consulting Research and experimental development on natural sciences and engineering Burdinne · balance sheet 912,045 €
- Phoenix Biosciences Manufacture of pharmaceutical preparations Nivelles · balance sheet €8.11m
- White Raven Manufacture of pharmaceutical preparations Liège · balance sheet €9.55m
- Etherna Immunotherapies Research and experimental development on natural sciences and engineering Niel · balance sheet €12.8m
Frequently asked questions about Groovy.Bio
What is the revenue of Groovy.Bio?
Groovy.Bio files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Groovy.Bio?
In Belgium, the VAT number is the company number prefixed with BE: BE0776937633 for Groovy.Bio, if the company is VAT-registered. Its company number (CBE) is 0776.937.633.
Where is the registered office of Groovy.Bio?
According to the CBE register, the registered office of Groovy.Bio is in 9940 Evergem.
What is the equity of Groovy.Bio?
At the close of the 2025 financial year, the equity of Groovy.Bio amounts to 544,484 €, a solvency of 73.2% of total assets.
How many people work at Groovy.Bio?
0.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Groovy.Bio?
The register lists 2 active mandates at Groovy.Bio. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Groovy.Bio
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →